HAOHAI BIOTEC (06826) intends to use temporarily idle funds raised for cash management.
Haohai Biological Technology (06826) issued an announcement to improve the efficiency of the use of funds raised, and to reasonably utilize some temporarily idle funds...
HAOHAI BIOTEC (06826) announced that in order to improve the efficiency of the use of raised funds, it will reasonably utilize some temporarily idle raised funds to increase the company's revenue, ensuring that it does not affect the construction and use of raised fund projects, and that the raised funds are safe and the purpose of the raised funds remains unchanged. The company plans to use up to 300 million yuan (including the principal) of temporarily idle raised funds for cash management, with a validity period of 12 months from the date of approval by the board of directors. Within the above-mentioned limit and period, the funds can be used in a revolving manner.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


